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Introduction
HIV-1 infection is characterized by a progressive loss of
CD4+ T cells. The role of apoptotic processes was identi-
fied recently, but a limited information is available so far.
The aim of this study was to compare levels of apoptosis
markers - cytokeratin 18 neoepitope (CK18) and cyto-
chrome C (CC) in different HIV infected patient groups.
Methods
There were 69 HIV infected patients enrolled in the study
and divided into four groups according to CD4+ T cell
count and presence of opportunistic infections (OI): 19
patients with CD4+ T cell count above 200 c/mcl without
OI, 15 patients with CD4+ T cell count below 200 c/mcl
without OI, 7 patients with CD4+ T cell count above 200
c/mcl with OI, 28 patients with CD4+ T cell count below
200 c/mcl with OI. Opportunistic infections included
tuberculosis, cryptococcosis, CMV infection, PCP. The
serum levels of cytokeratin 18 neoepitope and cytochrome
C were determined. Comparisons between groups were
made using paired T- test.
Results
CC levels were not significantly different between groups
with CD4+ cell count above and below 200 c/mcl (with
opportunistic infections 0,5>p>0,4, without opportunistic
infections p=0,5). Levels of CC were not significantly influ-
enced by presence of opportunistic infections (with CD4+
cell count above 200 c/mcl p=0,6, with CD4+ cell count
below 200 c/mcl p=0,7). We found significant diference of
CK18 levels between group without opportunistic infec-
tions and CD4+ cell count above 200 c/mcl (210,58
±26,98 u/l) and group without opportunistic infections
and CD4+ cell count above 200 c/mcl (132,95±14,09 u/l),
p=0,02, as well as between group without opportunistic
infections and CD4+ cell count below 200 c/mcl (132,95
±14,09 u/l) and group with opportunistic infections and
CD4+ cell count below 200 c/mcl (174,56±20,83 u/l),
0.02>p>0.01.
Conclusion
The results obtained from our study demonstrate eleva-
tion of levels of apoptosis serum markers early in HIV
infection which anticipate further decrease of CD4 cell
count.
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